(5 years, 10 months ago)
Commons ChamberI look forward to working with my hon. Friend and his local colleagues on what we can do to support Stepping Hill Hospital further. He is an assiduous representative for Hazel Grove who makes the argument very clearly, both to me and to the NHS Minister, who has already heard from him on several occasions. We did manage to provide £1 million for upgrades to Stepping Hill Hospital ahead of this winter and we understand the case that they make.
Since 1980, Aberdeen University has been at the forefront of MRI development. May I invite the Secretary of State to visit Aberdeen medical facilities to see the fast field-cycling scanner, a development of national importance to stroke diagnosis?
Yes, I love going to Aberdeen and look forward to another reason for going to the north-east. Of course, Aberdeen University and the UK have been at the cutting edge of this innovation for years and must be for years to come.
(6 years, 10 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is an honour to serve under you, Mr Wilson. I congratulate my hon. Friend the Member for Crawley (Henry Smith) on bringing the debate to the House. He mentioned the devolved Governments, and I would like to speak about my own part of the country.
In 2015 in the Grampian NHS Board area, which includes my constituency of Gordon, there were 265 new diagnoses of leukaemia, lymphoma or myeloma, forming one in every 12 diagnoses in the area that year. In the same year, 106 lives in the Grampian area were taken by these cancers. It is crucial, therefore, that we leave no stone unturned in the fight against blood cancers. That includes research and development, on which the UK Government have a strong record that I very much hope will continue. The life sciences sector deal announced last year will provide a welcome boost to the industry and help it to strive towards better ways of treating blood cancers
However, quality NHS care is also important. People with blood cancers deserve the best possible care from the NHS, wherever they are in the country. In that light, I would like to take this opportunity to pay tribute to the dedicated staff of Aberdeen Royal Infirmary, which serves my constituency and covers an area of 500,000 people; indeed, it covers the whole north-east of Scotland right up into the highlands. The work of the staff in its oncology department is second to none and has saved countless lives over the years. The start of treatment in Aberdeen Royal Infirmary’s new radiotherapy department in 2014 was a welcome step forward in the treatment of blood cancers and other cancers in the north-east of Scotland. That state-of-the-art new building has enabled the team to deliver new techniques and new forms of therapy to more and more patients—a development that can only be good.
The hard-working staff at Aberdeen Royal Infirmary deserve across the board support from the Scottish Government. However, as with Her Majesty’s Government, budgets are constrained. Oncology at the ARI has not been spared, unfortunately, from the long-running staff shortages. For a department that treats cancer patients not just in Gordon but across the north-east of Scotland and even further afield, that is obviously very concerning. Across Scotland, vacancy rates for consultants and nurses are disappointingly high, with 400 consultant posts now unfilled. Both north and south of the border, shortages are damaging. NHS staff and patients alike must have the security of knowing that their local oncology department is, and always will be, adequately staffed and given the support that it deserves.
My family’s experience of the oncology department at Aberdeen Royal Infirmary and of support from Macmillan nurses has been excellent. There are many ways we can take the fight to blood cancers. Research and development, which has been mentioned, is one vital pillar, and encouraging stem cell donations another. We must be sure to put NHS care at the very centre of our efforts.
(7 years ago)
Commons ChamberWhat an offer, Mr Speaker! Sustainability and transformation partnerships in all areas are to draw up local plans across one NHS area, including on the public health prevention agenda. I suggest that the hon. Gentleman volunteers his services to his local STP; I suspect it will take his hand off.
On 3 November, we published our response to the accelerated access review. We set out plans to give patients quicker access to life-changing treatments and to make the UK the best place in the world for industry to invest and innovate. We are delighted that Sir Andrew Witty will chair the group overseeing the accelerated access pathway, which will fast-track around five breakthrough products each year and support adoption and uptake of innovation across the NHS.
The technologies used at the neonatal unit at Aberdeen Royal Infirmary are now considered essential by my constituents in Gordon. The unit serves 500,000 people who live within 90 minutes of Aberdeen. What assessment has the Minister made of the importance of proximity of medical innovations to regional communities?
I am pleased to hear that from my hon. Friend. It is good to know that we are on track to achieve our ambition to reduce the rates of stillbirth, neonatal and maternal deaths and perinatal brain injuries by 20% by 2020. Innovations such as those in Aberdeen have contributed to that work. It is important that our regional communities have access to specialist care of the kind my hon. Friend describes, and we hope to deliver more through the accelerated access pathway.
(7 years ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
I congratulate my hon. Friend the Member for Dartford (Gareth Johnson) on bringing forward this topical issue for debate. I want to reflect on his comments about the ever-increasing popularity of vaping. The evidence is clear that vaping is less harmful than smoking, as it does not contain many of the harmful substances produced by smoking tobacco, such as tar or carbon monoxide.
When vaping was first introduced, it was targeted mainly at regular smokers attracted by the healthy alternative. In 2015, the Office for National Statistics noted that 50% of vapers were using it as an aid to stop smoking; 10% of them cited cheaper prices as the main reason for using e-cigarettes. Within a year, both numbers dropped, to 46% and 8.1% citing the cheaper price. One explanation that is frequently given nowadays is the perception that e-cigarettes are less harmful than cigarettes, but also, more strikingly, the range of different flavours available. That was cited in only 1% of cases in 2015, but it climbed to 5% within just one year.
Those numbers clearly reveal an effort made by vaping companies to diversify their customers and expand their market. My question and concern is whether vaping makes smoking more fashionable, particularly among the young. In my Gordon constituency, there are three vaping shops in the small town of Inverurie, which has a population of 15,000. That is hardly due to more traditional smokers looking to quit; it is, rather, due to non-smokers picking up vaping. However, they may be people who were going to turn to smoking anyway, particularly the young. Again, here the statistics speak for themselves. In 2015, only 2.8% of 16 to 24-year-olds were e-cigarette users, while 5.8% of them were users in 2016. The number of male users in that age category has more than doubled, so it looks as if young men who might perhaps have taken up smoking have turned to vaping instead.
Although vaping is indeed less harmful than traditional cigarettes, it still contains nicotine. I am also concerned about the misuse of e-cigarettes as a way of abusing other substances such as drugs, but I keep in mind the very powerful lobby with a vested interest in maligning the vaping industry.
Whether or not more people pick up the habit as a result of successful marketing campaigns, the biggest benefit is to those around vapers or smokers. Vaping is a matter of personal choice and, unlike smoking, it does not affect the health of those around the vaper. Passive smoking kills 600,000 people annually worldwide and is one of the major causes of lung cancer, and it is particularly dangerous for children. That makes vaping by far the better choice for those around people who choose to have the habit. I agree with my hon. Friend the Member for Dartford and would encourage the Minister to engage with the vaping industry. Tobacco blights the health of our society.